Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3125702 (Amg 232, AMG 232, AMG-232, Krt-232, KRT-232, Mdm2 inhibitor amg-232, Navtemadlin) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
MDM2 proto-oncogene/p53-binding protein Mdm-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5023] [GtoPdb: 3136] [UniProtKB: Q00987] | ||||||||
ChEMBL | Binding affinity to human MDM2 by by Surface Plasmon Resonace (SPR) spectroscopy binding assay | B | 10.35 | pKd | 0.04 | nM | Kd | J Med Chem (2014) 57: 1454-1472 [PMID:24456472] |
ChEMBL | Binding affinity to human MDM2 by by surface plasmon resonace spectroscopy | B | 10.35 | pKd | 0.04 | nM | Kd | J Med Chem (2014) 57: 10499-10511 [PMID:25384157] |
GtoPdb | Binding affinity determined in a SPR assay, measuring inhibition of interaction between human p53 and recombinant MDM2. | - | 10.35 | pKd | 0.05 | nM | Kd | J Med Chem (2014) 57: 1454-72 [PMID:24456472] |
ChEMBL | Binding affinity to human MDM2 by by isothermal titration calorimetry | B | 10.42 | pKd | 0.04 | nM | Kd | J Med Chem (2014) 57: 10499-10511 [PMID:25384157] |
ChEMBL | Binding affinity to MDM2 in human SJSA1 cells assessed as induction of p21 gene level after 7 hrs by qRT-PCR assay in presence of 10% human serum | B | 7.33 | pIC50 | 47 | nM | IC50 | J Med Chem (2014) 57: 10499-10511 [PMID:25384157] |
ChEMBL | Binding affinity to human GST-thrombin-tagged MDM2 ( 1 to 188 aa) assessed as inhibition of interaction with human p53 preincubated with compound for 20 mins by HTRF assay | B | 9.2 | pIC50 | 0.63 | nM | IC50 | J Med Chem (2014) 57: 10499-10511 [PMID:25384157] |
ChEMBL | Binding affinity to human GST-thrombin-tagged MDM2 assessed as inhibition of interaction with human p53 after 1 hr by HTRF assay | B | 9.22 | pIC50 | 0.6 | nM | IC50 | J Med Chem (2014) 57: 1454-1472 [PMID:24456472] |
ChEMBL | Inhibition of MDM2 (unknown origin) | B | 9.22 | pIC50 | 0.6 | nM | IC50 | Eur J Med Chem (2019) 176: 476-491 [PMID:31128449] |
Protein Mdm4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1255126] [UniProtKB: O15151] | ||||||||
ChEMBL | Inhibition of MDM4 (unknown origin) | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2022) 65: 6207-6230 [PMID:35420431] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]